Along with our recent study demonstrating in vitro and in vivo antitumour effect of anti-CD26 antibody (Ho et al, 2001), our current work may therefore provide additional insights into the potential treatment strategies for selected cancers based on CD26 biology. This evidence concerns the gene DPP4 and cancer.